LATIN AMERICA PHARMACEUTICAL PRODUCTS CMO MARKET ANALYSIS

Latin America Pharmaceutical Products CMO Market, by Product Type (API and Ingredients, Finished Dosage Form, and Pharmaceutical Packaging) and by Country (Brazil, Mexico, Argentina, and Rest of Latin America) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027

Published In : Feb 2021
Code : CMI3933
Pages :151
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenges And Opportunities

Latin America Pharmaceutical Products CMO Market Restraint

The pharmaceutical industry in Mexico does not operate through an established system of reimbursement and there is minimal reimbursement offered outside the hospital settings. Reimbursement is limited to generic drugs, based on health technology assessment and to the under privileged population. Such scenario is expected to hinder growth of Latin America Pharmaceutical Products CMO Market.

Restraints & Challenges: